Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma and Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and Blastomyces pathogens in a single test.

(00:32)
Will you please give us a brief introduction of yourself and your role at Mayo Clinic?

(01:34)
 Can you tell us which specific group of patients this test would be best suited for, how a provider would determine a patient might benefit from this test, and when during the care process it should be ordered?

(04:56)
 Can you explain how this new test is different, and why a provider might consider requesting it instead of the usual test?

(08:00)
 When should the different tests be used?

(09:34)
 Is this the only existing assay that can reliably detect antigen from both of these fungal pathogens?